Fleischmann M - Search Results

1

Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.

Kiener R, Fleischmann M, Wiegand MA, Lemmermann NAW, Schwegler C, Kaufmann C, Renzaho A, Thomas S, Felder E, Niller HH, Asbach B, Wagner R. Kiener R, et al. Among authors: fleischmann m. J Virol. 2018 Jul 17;92(15):e00569-18. doi: 10.1128/JVI.00569-18. Print 2018 Aug 1. J Virol. 2018. PMID: 29769344 Free PMC article.

2

Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo.

Kiener R, Fleischmann M, Schwegler C, Ruzsics Z, Thirion C, Schrödel S, Asbach B, Wagner R. Kiener R, et al. Among authors: fleischmann m. Sci Rep. 2018 Jan 24;8(1):1474. doi: 10.1038/s41598-018-19874-1. Sci Rep. 2018. PMID: 29367743 Free PMC article.

3

Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease.

Anderson BM, Poole DP, Aurelio L, Ng GZ, Fleischmann M, Kasperkiewicz P, Morissette C, Drag M, van Driel IR, Schmidt BL, Vanner SJ, Bunnett NW, Edgington-Mitchell LE. Anderson BM, et al. Among authors: fleischmann m. Sci Rep. 2019 Sep 16;9(1):13295. doi: 10.1038/s41598-019-49840-4. Sci Rep. 2019. PMID: 31527638 Free PMC article.

4

How do Australian osteopaths manage migraines? Outcomes from a national practice-based research network.

Fleischmann M, Vaughan B, Campbell C, Ekberg J, Evans M, Green M, Ong A, Pitrone G, Lane R, Adams J. Fleischmann M, et al. J Bodyw Mov Ther. 2024 Apr;38:489-497. doi: 10.1016/j.jbmt.2024.03.041. Epub 2024 Mar 26. J Bodyw Mov Ther. 2024. PMID: 38763598 Free article.

5

Opposing roles of resident and infiltrating immune cells in the defence against Legionella longbeachae via IL-18R/IFN-γ/ROS axis in mice.

Oberkircher LM, Scheiding VM, Linda Rafeld H, Hanssen E, Hansen JN, Fleischmann MJ, Kessler N, Pitsch D, Wachten D, Kastenmüller W, Brown AS, Hartland EL, van Driel IR, Ng GZ, Garbi N. Oberkircher LM, et al. Among authors: fleischmann mj. Mucosal Immunol. 2024 May 13:S1933-0219(24)00042-4. doi: 10.1016/j.mucimm.2024.05.001. Online ahead of print. Mucosal Immunol. 2024. PMID: 38750967 Free article.

6

Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer.

Arends CM, Kopp K, Hablesreiter R, Estrada N, Christen F, Moll UM, Zeillinger R, Schmitt WD, Sehouli J, Kulbe H, Fleischmann M, Ray-Coquard I, Zeimet A, Raspagliesi F, Zamagni C, Vergote I, Lorusso D, Concin N, Bullinger L, Braicu EI, Damm F. Arends CM, et al. Among authors: fleischmann m. Leukemia. 2024 May 7. doi: 10.1038/s41375-024-02274-y. Online ahead of print. Leukemia. 2024. PMID: 38714878 No abstract available.

7

MRI-based radiomics for predicting histology in malignant salivary gland tumors: methodology and "proof of principle".

Khodabakhshi Z, Motisi L, Bink A, Broglie MA, Rupp NJ, Fleischmann M, von der Grün J, Guckenberger M, Tanadini-Lang S, Balermpas P. Khodabakhshi Z, et al. Among authors: fleischmann m. Sci Rep. 2024 Apr 30;14(1):9945. doi: 10.1038/s41598-024-60200-9. Sci Rep. 2024. PMID: 38688932 Free PMC article.

8

Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma.

Martin D, Rödel F, Hehlgans S, Looso M, Ziegler PK, Fleischmann M, Diefenhardt M, Fries L, Kalinauskaite G, Tinhofer I, Zips D, Gani C, Rödel C, Fokas E. Martin D, et al. Among authors: fleischmann m. NPJ Precis Oncol. 2024 Apr 23;8(1):93. doi: 10.1038/s41698-024-00585-y. NPJ Precis Oncol. 2024. PMID: 38653773 Free PMC article.

9

Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer.

Arends CM, Kopp K, Hablesreiter R, Estrada N, Christen F, Moll UM, Zeillinger R, Schmitt WD, Sehouli J, Kulbe H, Fleischmann M, Ray-Coquard I, Zeimet A, Raspagliesi F, Zamagni C, Vergote I, Lorusso D, Concin N, Bullinger L, Braicu EI, Damm F. Arends CM, et al. Among authors: fleischmann m. Leukemia. 2024 Apr 18. doi: 10.1038/s41375-024-02253-3. Online ahead of print. Leukemia. 2024. PMID: 38637689

10

Synergistic Effects of the RARalpha Agonist Tamibarotene and the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Cells with KMT2A Rearrangement or NPM1 Mutation.

Fleischmann M, Bechwar J, Voigtländer D, Fischer M, Schnetzke U, Hochhaus A, Scholl S. Fleischmann M, et al. Cancers (Basel). 2024 Mar 28;16(7):1311. doi: 10.3390/cancers16071311. Cancers (Basel). 2024. PMID: 38610989 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page